Scientists at the Gladstone Institutes have discovered a bacterial defense system that operates in reverse of previously known mechanisms, a finding that could open new avenues for gene editing and antibiotic development. The research, published in Molecular Cell on October 13, 2026, describes how type VI retrons produce little DNA or toxin in healthy cells but ramp up production when a virus attacks, triggering a self-destruct that protects the bacterial colony.
The discovery came when the researchers noticed that type VI retrons lacked the single-stranded DNA signature typical of other retron defenses. "The way we typically detect retrons inside uninfected cells is by looking for this single-stranded DNA," said Karen Zhang, a PhD student in Shipman's lab and lead author. "But type VI retrons caught our attention because they didn't appear to have this signature. It was very odd, and we wondered if they might be broken."
Despite the missing signature, the retrons were functional. "That kicked off a long molecular odyssey," said Gladstone Investigator Seth Shipman, senior author. "Whenever we tried the experiments we normally use to study retrons, they would fail, so we kept having to think of new ways to figure out how these retrons work."
Retrons are bacterial immune systems that sacrifice an infected cell to prevent a virus from spreading. In most known retrons, a toxin is already present but held in check by single-stranded DNA, and infection disrupts that protection, allowing the toxin to act. Type VI retrons produce very little DNA and no noticeable amount of toxin in healthy cells. A phage triggers increased DNA production, which interacts with an RNA molecule that has been blocking toxin synthesis. This interaction lifts the restriction, enabling the cell to make a small protein that inserts into and disrupts the cell membrane, causing the cell to die.
"It's almost the mirror-image version of how we traditionally view retrons," Zhang said.
The work required new experimental strategies and adaptations of existing methods, including a technique called Spacer-seq developed in Shipman's lab, which uses CRISPR-Cas machinery to record molecular activity. This approach finally detected trace amounts of single-stranded DNA in uninfected cells that earlier tests had missed.
The discovery is already influencing research on synthetic molecular sensors and switches that could regulate gene activity. Researchers are also exploring whether the retron's unusually small toxin could be adapted into new antimicrobial treatments. "This study highlights why it's so important for a molecular technology development lab like ours to keep looking to nature for inspiration," Shipman said.
Analysis
Why This Matters
- The backward-acting defense could provide a new blueprint for designing precision gene-editing tools that correct harmful mutations.
- The small toxin may be developed into novel antibiotics to combat drug-resistant bacterial infections.
- Understanding this unusual immune system expands fundamental knowledge of bacterial evolution and molecular mechanisms.
Background
Bacteria face constant threats from viruses called phages. Over time, bacteria have evolved a variety of immune defenses, among them retrons. In previously studied retrons, a toxic protein is already present inside a cell but suppressed by short strands of DNA; infection disrupts this, allowing the toxin to act. The newly discovered type VI retrons work in the opposite way: DNA switches on toxin production only after infection. This complexity challenged existing experimental methods, requiring the team to develop new approaches.
What to Watch
- Whether the type VI retron can be engineered into DNA-editing tools that work with greater precision than current CRISPR-based methods.
- Progress toward adapting the retron's small membrane-disrupting protein into a new class of antibiotics.
- Further evolutionary studies investigating how such a complex system arose and whether it represents a stepping stone between different retron types.
Checked
12 claims in this story checked against 1 source: 12 supported.
Show each claim
- SupportedGladstone scientists discovered a bacterial defense system that works in reverse of previously known defenses.Latest Science News -- ScienceDaily: “Scientists at Gladstone Institutes have discovered an unusual bacterial immune system that operates in almost the opposite way of previously known defenses.”
- SupportedType VI retrons activate toxin production after infection, reversing the usual mechanism.Latest Science News -- ScienceDaily: “Unlike other retrons, these systems rely on DNA to activate a toxin rather than keep one suppressed.”
- SupportedThe discovery could open avenues for gene editing and antibiotic development.Latest Science News -- ScienceDaily: “The surprising mechanism allows bacteria to activate a deadly self-destruct process when viruses attack, potentially offering new ideas for developing medical treatments and gene-editing technologies.”
- SupportedThe research was published in Molecular Cell on October 13, 2026.Latest Science News -- ScienceDaily: “The research, "Reverse transcribed ssDNA derepresses translation of a retron antiviral protein," was published in Molecular Cell on October 13, 2026.”
- SupportedKaren Zhang said type VI retrons caught researchers’ attention because they lacked the usual single-stranded DNA signature, and they wondered if they were broken.Latest Science News -- ScienceDaily: “"But type VI retrons caught our attention because they didn't appear to have this signature. It was very odd, and we wondered if they might be broken."”
- SupportedSeth Shipman said the discovery began a “long molecular odyssey” after usual experiments failed.Latest Science News -- ScienceDaily: “"That kicked off a long molecular odyssey," Shipman says. "Whenever we tried the experiments we normally use to study retrons, they would fail, so we kept having to think of new ways to figure out how these retrons work."”
- SupportedIn previously studied retrons, a toxin is already present and single-stranded DNA holds its harmful effects in check; infection disrupts that protection.Latest Science News -- ScienceDaily: “In previously studied retrons, a toxic protein is already present inside an uninfected cell, but its harmful effects are held in check by short pieces of single-stranded DNA. When a phage infects the bacterium, it disrupts this protective arrangement, allowing the toxin to act.”
- SupportedIn healthy cells, type VI retrons produce little DNA and no noticeable toxin; phage infection increases DNA production, which removes an RNA-based block on toxin production.Latest Science News -- ScienceDaily: “these retrons produce little detectable DNA and no noticeable amount of toxin in healthy cells. The arrival of a phage triggers a sharp increase in DNA production. As the DNA accumulates, it interacts with an RNA molecule that has been preventing the toxin from being made.”
- SupportedZhang described the mechanism as “almost the mirror-image version” of how retrons are traditionally viewed.Latest Science News -- ScienceDaily: “"It's almost the mirror-image version of how we traditionally view retrons, because the DNA switches on toxin production instead of inhibiting an already-produced toxin," Zhang says.”
- SupportedSpacer-seq, developed in Shipman’s laboratory and using CRISPR-Cas components, revealed trace single-stranded DNA in uninfected cells that earlier experiments had missed.Latest Science News -- ScienceDaily: “the researchers tried a technique called Spacer-seq, which had previously been developed in Shipman's laboratory. The method uses components of CRISPR-Cas ... The alternative approach finally revealed a trace amount of single-stranded DNA that earlier experiments had missed.”
- SupportedResearchers are exploring synthetic molecular sensors and switches and whether the retron’s small toxin could be adapted into antimicrobial treatments.Latest Science News -- ScienceDaily: “scientists are exploring ways to transform the type VI retron's natural machinery into useful technologies. One promising application involves developing synthetic molecular sensors and switches that can regulate gene activity.”
- SupportedShipman said the study shows why a molecular technology development lab should keep looking to nature for inspiration.Latest Science News -- ScienceDaily: “"This study highlights why it's so important for a molecular technology development lab like ours to keep looking to nature for inspiration," Shipman says.”
